Skip to main content

8-K

Genpact LTD (G)

8-K 2026-04-29 For: 2026-04-23
View Original
Added on April 29, 2026
View as plain text

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 23, 2026

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda 001-33626 98-0533350
(State or other jurisdiction<br>of incorporation) (Commission<br>     File Number) (I.R.S. Employer<br>Identification No.)

Canon's Court, 22 Victoria Street

Hamilton HM 12, Bermuda

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (441) 298-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered
Common shares, par value $0.01 per share G New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07    Submission of Matters to a Vote of Security Holders

On April 23, 2026, Genpact Limited, a Bermuda company (the “Company”), held its 2026 annual general meeting of shareholders (the “Annual Meeting”) at 521 Fifth Avenue, 14th Floor, New York, NY. At the Annual Meeting, Company shareholders voted on three proposals. The full results of the votes are set forth below. Each proposal is described in detail in the Company’s previously filed Proxy Statement related to the Annual Meeting.

Proposal 1

Company shareholders elected each of the nominees to the Company’s Board of Directors as set forth below:

Director Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes
Balkrishan Kalra 135,442,084 404,849 47,997 9,589,913
James Madden 128,675,764 7,166,730 52,436 9,589,913
Laura Conigliaro 131,407,566 4,438,426 48,938 9,589,913
Nicholas Gangestad 135,761,342 88,752 44,836 9,589,913
John Hinshaw 135,717,053 131,972 45,905 9,589,913
Carol Lindstrom 132,572,200 3,250,900 71,830 9,589,913
CeCelia Morken 134,719,348 1,127,586 47,996 9,589,913
Brian Stevens 135,791,886 58,240 44,804 9,589,913
Thimaya Subaiya 135,760,871 92,231 41,828 9,589,913
Mark Verdi 135,035,615 806,679 52,636 9,589,913

Proposal 2

Company shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as set forth below:

Votes cast in favor 125,882,016
Votes cast against 9,847,642
Votes abstaining 165,272
Broker non-votes 9,589,913

Proposal 3

Company shareholders approved the appointment of KPMG Assurance and Consulting Services LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year as set forth below:

Votes cast in favor 134,484,965
Votes cast against 10,944,301
Votes abstaining 55,577

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENPACT LIMITED
Date: April 29, 2026 By: /s/ Sydney Schaub
Name: Sydney Schaub
Title: Senior Vice President, Chief Legal Officer and Secretary